Switch to:

Intra-Cellular Therapies Days Sales Outstanding

: 92.64 (As of Sep. 2020)
View and export this data going back to 2013. Start your Free Trial

Intra-Cellular Therapies's Accounts Receivable for the three months ended in Sep. 2020 was $7.48 Mil. Intra-Cellular Therapies's Revenue for the three months ended in Sep. 2020 was $7.37 Mil. Hence, Intra-Cellular Therapies's days sales outstanding for the three months ended in Sep. 2020 was 92.64.

NAS:ITCI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 32.89   Med: 103.66   Max: 262.05
Current: 262.05

32.89
262.05

During the past 8 years, Intra-Cellular Therapies's highest Days Sales Outstanding was 262.05. The lowest was 32.89. And the median was 103.66.

NAS:ITCI's Days Sales Outstanding is ranked lower than
89% of the 728 Companies
in the Biotechnology industry.

( Industry Median: 68.75 vs. NAS:ITCI: 262.05 )

Intra-Cellular Therapies's days sales outstanding increased from Sep. 2019 (0.00) to Sep. 2020 (92.64).


Intra-Cellular Therapies Days Sales Outstanding Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Intra-Cellular Therapies Annual Data
Dec12 Mar13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Days Sales Outstanding Premium Member Only Premium Member Only Premium Member Only 124.34 103.66 0.00 0.00 0.00

Intra-Cellular Therapies Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Days Sales Outstanding Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 113.83 112.59 92.64

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Intra-Cellular Therapies Days Sales Outstanding Distribution

* The bar in red indicates where Intra-Cellular Therapies's Days Sales Outstanding falls into.



Intra-Cellular Therapies Days Sales Outstanding Calculation

Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Intra-Cellular Therapies's Days Sales Outstanding for the fiscal year that ended in Dec. 2019 is calculated as

Days Sales Outstanding=Accounts Receivable/Revenue*Days in Period
=0/0.061*365
=0.00

Intra-Cellular Therapies's Days Sales Outstanding for the quarter that ended in Sep. 2020 is calculated as:

Days Sales Outstanding=Accounts Receivable/Revenue*Days in Period
=7.481/7.369*365 / 4
=92.64

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Intra-Cellular Therapies  (NAS:ITCI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Intra-Cellular Therapies Days Sales Outstanding Related Terms


Intra-Cellular Therapies Days Sales Outstanding Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)